HIV study uses consumer advisory boards to assist with trial recruitment

April 2008
Clinical Trials Administrator;Apr2008, Vol. 6 Issue 4, p46
The article reports on the use of consumer advisory boards (CAB) to assist with trial recruitment for a study involving human immunodeficiency virus prevention among homeless and mentally ill people. Stephen Brady, director of mental health and behavioral medicine program and associate professor at Boston University School of Medicine in Boston, Massachusetts, says they have a consumer board that is fantastic. He says the research team found volunteers for the CAB by networking with a state mental health authority and an HIV/AIDS organization.


Related Articles

  • Predictors of Frequent Emergency Room Visits among a Homeless Population. Thakarar, Kinna; Morgan, Jake R.; Gaeta, Jessie M.; Hohl, Carole; Drainoni, Mari-Lynn // PLoS ONE;Apr2015, Vol. 10 Issue 4, p1 

    Background: Homelessness, HIV, and substance use are interwoven problems. Furthermore, homeless individuals are frequent users of emergency services. The main purpose of this study was to identify risk factors for frequent emergency room (ER) visits and to examine the effects of housing status...

  • Preventing Recurrent Homelessness among Mentally Ill Men: A "Critical Time" Intervention after Discharge from a Shelter. Susser, Ezra; Valencia, Elie; Conover, Sarah; Felix, Alan; Wei-Yann Tsai; Wyatt, Richard Jed // American Journal of Public Health;Feb1997, Vol. 87 Issue 2, p256 

    The article presents a study which examines a strategy to prevent homelessness among individuals with severe mental illness, by providing a bridge between institutional and community care. This randomized clinical trial tested an approach to prevent homelessness among mentally ill individuals....

  • Vancouver At Home: pragmatic randomized trials investigating Housing First for homeless and mentally ill adults. Somers, Julian M.; Patterson, Michelle L.; Moniruzzaman, Akm; Currie, Lauren; Rezansoff, Stefanie N.; Palepu, Anita; Fryer, Karen // Trials;2013, Vol. 14 Issue 1, p1 

    Background Individuals with mental illnesses are overrepresented among the homeless. Housing First (HF) has been shown to promote positive outcomes in this population. However, key questions remain unresolved, including: how to match support services to client needs, the benefits of housing in...

  • Funding for HIV network extended.  // CMAJ: Canadian Medical Association Journal;06/01/97, Vol. 156 Issue 11, p1524 

    Reports on the extension of the federal government's stable funding for the Canadian HIV Trials Network (CTN). Research projects of the organization; National director of the group.

  • Psychiatric disorders among the homeless: A comparison of older and younger groups. DeMallie, Dianne A.; North, Carol S. // Gerontologist;Feb97, Vol. 37 Issue 1, p61 

    Identifies differences in psychiatric disorders between older and younger homeless subgroups. Interview process using the National Institute of Mental Health Diagnostic Interview Schedule; Demographic categories of subjects; Prevalence of lifetime psychiatric diagnoses; Criteria for lifetime...

  • Guidelines for Improving Entry Into and Retention in Care and Antiretroviral Adherence for Persons With HIV: Evidence-Based Recommendations From an International Association of Physicians in AIDS Care Panel. Thompson, Melanie A.; Mugavero, Michael J.; Amico, K. Rivet; Cargill, Victoria A.; Chang, Larry W.; Gross, Robert; Orrell, Catherine; Altice, Frederick L.; Bangsberg, David R.; Bartlett, John G.; Beckwith, Curt G.; Dowshen, Nadia; Gordon, Christopher M.; Horn, Tim; Kumar, Princy; Scott, James D.; Stirratt, Michael J.; Remien, Robert H.; Simoni, Jane M.; Nachega, Jean B. // Annals of Internal Medicine;6/5/2012, Vol. 156 Issue 11, following p817 

    Description: After HIV diagnosis, timely entry into HIV medical care and retention in that care are essential to the provision of effective antiretroviral therapy (ART). Adherence to ART is among the key determinants of successful HIV treatment outcome and is essential to minimize the emergence...

  • A single dose of live oral cholera vaccine CVD 103-HgR is safe and immunogenic in HIV-noninfected... Perry, R.T.; Plowe, C.V.; Koumaré, B.; Bougoudogo, F.; Kotloff, K.L.; Losonsky, G.A.; Wasserman, S.S.; Levine, M.M. // Bulletin of the World Health Organization;1998, Vol. 76 Issue 1, p63 

    Provides information on randomized clinical trials conducted in Mali on adults who are infected with the Human Immunodeficiency Virus (HIV), with focus on the use of a single dose of live oral cholera vaccine. Details on the seventh cholera pandemic caused by Vibrio cholerae; Methodology used...

  • One STEP forward, two steps back.  // AIDS Alert;Jun2008, Vol. 23 Issue 6, p68 

    The article reports that the STEP trial, a scientific concept tested in the HIV vaccine, did not produce the desired beneficial effect, according to Anthony S. Fauci, director at the National Institute of Allergy and Infectious Diseases National Institutes of Health (NIAID).

  • HIV trials instructive to other researchers.  // AIDS Alert;Sep2009, Vol. 24 Issue 9, p103 

    The article reports on the effort of HIV investigators and research sponsors to develop new ways to educate communities about HIV clinical trials in the U.S.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics